ScienceT2 · Outlet report
Some people are losing too much weight in Retatrutide trial.
Randomized trial results of the experimental GLP-1, GIP, and glucagon drug shows that it may be too effective, while causing a whopping 11% of participants at the highest dose to…
1 update1 source1 mention here
May 21, 2026
Latest: Some people are losing too much weight in Retatrutide trial. · The Verge
